Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test;Valoración de la calidad de la colonoscopia en un programa de cribado masivo poblacional basado en la prueba de sangre oculta en heces

Revista Espanola de Enfermedades Digestivas

Volumn 105, Issue 7, 2013, Pages 400-408

  Binefa, Gemma ^a,b   García, Montse ^a   Milà, Núria ^a   Rodríguez, Lorena ^c   Rodríguez Moranta, Francisco ^c   Guardiola, Jordi ^c   Moreno, Víctor ^a,b  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Colonoscopy; Colorectal cancer; Mass screening programme; Quality indicators

Indexed keywords

GUAIAC;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; BIOPSY; CANCER SCREENING; CANCER STAGING; COLON LAVAGE; COLON PERFORATION; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; QUALITY CONTROL; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; EVALUATION STUDY; HEALTH CARE QUALITY; MASS SCREENING; MIDDLE AGED; STANDARDS;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE;

EID: 84890504526     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082013000700005     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOB-OCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer 2010. Available at: http://globocan.iarc.fr [accessed on 09/07/2013].
2. López-Abente G, Ardanaz E, Torrella-Ramos A, Mateos A, Delga-do-Sanz C, Chirlaque MD. Changes in colorectal cancer incidence and mortality trends in Spain. Ann Oncol 2010;21(Supl.3):iii76-iii82.
3. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-781.
4. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. Am J Gastroenterol 2008;103:1541-1549.
5. Europe against colorectal cancer. Declaration of Brussels, 9 may 2007. Available at: http://www.future-health-2007.com [Accessed August 2013].
6. Von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on Cancer Screening. International Agency for Research of Cancer. European Communities; 2008.
7. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Cancer 2008;122:1357-1367.
8. Peris M, Espinas JA, Muñoz L, Navarro M, Binefa G, Borràs JM. Lessons learnt from a population-based pilot program for colorectal cancer screening in Catalonia (Spain). J Med Screen 2007;14:81-86.
9. Red de Programas de Cribado de Cáncer. Available at: http://www.cribadocancer.com/index.php/cancer-colorrectal/red-de-pro-gramas-de-cribado-espanoles/situacion [Accessed August 2013].
10. Borras JM, Colomer C, Soria P, López R. Priorities for cancer control in Spain. Ann Oncol 2010;21(Supl. 3):iii111-iii114.
11. Allison J. The best screening test for colorectal cancer is the one that gets done well. Gastrointest Endosc 2010;71:342-345.
12. Bretagne JF, Hamonic S, Piette C, Manfredi S, Leray E, Durand G, et al. Variations between endoscopists in rates of detection of colorectal neopla-sia and their impact on a regional screening program based on colonosco-py after fecal occult blood testing. Gastrointest Endosc 2010;71:335-341.
13. Macken E, Moreels T, Vannoote J, Siersema PD, Van Cutsem E. Quality assurance in colonoscopy for colorectal cancer diagnosis. Eur J Surg Oncol 2011;37:10-15.
14. Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L. Analysis of administrative data fnds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 2011;140:65-72.
15. Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. Quality indicators for colonoscopy and the risk of interval cancer. New Engl J Med 2010;362:1795-1803.
16. Navarro M, Binefa G, Blanco I, Guardiola J, Rodríguez-Moranta F, Peris M. Colorectal cancer screening: Strategies to select populations with moderate risk for disease. Rev Esp Enferm Dig 2009;101:855-860.
17. García M, Binefa G, Milà N, Rodríguez F, Gonzalo N, Muñoz C, et al. Evaluación de dos estrategias de cribado de cáncer colorrectal: test inmunológico versus test bioquímico. Cataluña, 2008-2010. Rev Esp Salud Publica 2011;85:593-602.
18. Clinical practice guide for colorectal cancer. 2009 update. AEG, Sem-FyC y Centro Cochrane Iberoamericano. Barcelona: Elsevier; 2009 [in Spanish].
19. Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006;101:873-885.
20. Lorenzo-Zúñiga V, Moreno-de-Vega, V, Boix J. Preparation for colo-noscopy: types of scales and cleaning products. Rev Esp Enferm Dig 2012;104:426-431.
21. Valori R, Rey FJ, Atkin W, Michael Bretthauer, Carlo Senore, Geir Hoff, et al. Guidelines for quality assurance of endoscopy in colorectal cancer screening (and diagnosis). In: Patnick J, Segnan N, Vo n Karsa L, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg: European Commission, Publications Offce of the European Union; 2010: doi:10.2772/1458.
22. Grupo de trabajo de la Asociación Española de Gastroenterología y de la Sociedad Española de Endoscopia Digestiva. Guía de Práctica Clínica de Calidad en la colonoscopia de cribado del cáncer colorrectal. Madrid: EDIMSA. Editores Médicos S.A., 2011.
23. Imperialli G, Minolli G, Meucci M, Spinzi G, Strocchi E, Terruzzi V, et al. Effectiveness of a continuous quality improvement program on colonoscopy practice. Endoscopy 2007;39:314-8.
24. Rex DK. Maximizing detection of adenomas and cancers during colo-noscopy. Am J Gastroenterol 2006;101:2866-2877.
25. Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in prediction adenoma detection at colonoscopy. Am J Gastroenterol 2007;102:856-861.
26. Rex DK, Hewett DG, Snover DC. Detection targets for colonos-copy: From variable detection to validation. Am J Gastroenterol 2010;105:2665-2669.
27. Corley DA, Jensen CH, Marks AM. Can we improve adenoma detection rates? A systematic review of intervention studies. Gastrointest Endosc 2011;74:656-65.
28. Lee TJW, Rutter MD, Blanks RG, Moss SM, Goddard AF, Chilton A, et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 2012;61:1050-1057.
29. Morán S, Torrella E, Esteban P, Baños R, García A, Ono A, et al. Colo-noscopy quality assessment. Rev Esp Enferm Dig 2009;101:107-112.
30. Robertson DJ, Geenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005;129:34-41.
31. Lieberman D, Nadel M, Smith R, Atkin W, Duggirala SB, Fletcher R, et al. Standardized colonoscopy reporting and data system: Report of the Quality Assurance Task Force Group of the National Colorectal Cancer Roundtable. Gastrointestinal Endosc 2007;65:757-766.
32. García M, Milà N, Binefa G, Borràs JM, Espinàs JA, Moreno V. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010. J Med Screen 2012;19:77-82.
33. Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010;105:2017-2025.
34. Levi Z, Birkenfeld S, Vilkin A, Bar-Chana M, Lifshitz I, Chared M, et al. A higher detection rate for colorectal cancer and advanced adeno-matous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. Int J Cancer 2011;128:2415-2424.
35. Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: Evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2010;105:682-690.
36. Crotta S, Segnan N, Paganin S, Dagnes B, Rosset R, Senore C. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 2012;10:633-638.
37. Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut 2012;61:101-107.
38. Zubarik R, Fleischer DE, Mastropietro C, López J, Carroll J, Benjamin S, et al. Prospective analysis of complications 30 days after outpatient colonoscopy. Gastrointest Endosc 1999;50:322-328.
39. Valori R, Nicolaas JS, de Jonge V. Quality assurance of endoscopy in col-orectal cancer screening. Best Prac Res Clin Gastroenterol 2010;24:451-464.